| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/01/2011 | CN101534816B External composition for skin containing manassantin b as active ingredient and the use thereof for skin whitening |
| 06/01/2011 | CN101532997B Production control of platinum-based anti-cancer drugs and method for measuring micro silver in product |
| 06/01/2011 | CN101500998B Mono-and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action |
| 06/01/2011 | CN101495150B Pharmaceutical composition improved in absorption of pharmacologically active substance |
| 06/01/2011 | CN101485645B Elemene transdermal agent and preparation method thereof |
| 06/01/2011 | CN101475599B Novel method for synthesizing antineoplastic medicament nedaplatin |
| 06/01/2011 | CN101454003B Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 06/01/2011 | CN101450087B Adonis amurensis total-flavone mouth plaster |
| 06/01/2011 | CN101444555B Purely Chinese traditional medical film for curing oral ulcer and method for preparing same |
| 06/01/2011 | CN101432262B Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/01/2011 | CN101421242B Dicarboxamide derivatives |
| 06/01/2011 | CN101416957B Use of resveratrol or naringenin in preventing and treating diabetic nephropathy |
| 06/01/2011 | CN101411705B Pharmaceutical composition for preventing and treating atherosclerosis |
| 06/01/2011 | CN101396488B Medicine for treating chronic faucitis |
| 06/01/2011 | CN101396370B Medicine composition for treating mouth, throat disease and preparation method thereof |
| 06/01/2011 | CN101380402B Ointment for treating burn and scald and preparation method thereof |
| 06/01/2011 | CN101379036B Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 06/01/2011 | CN101376624B Cinnamomum kanehirae Hayata pimelie kelone compound for liver protection |
| 06/01/2011 | CN101370484B Solid pharmaceutical composition comprising irbesartan |
| 06/01/2011 | CN101367840B Phosphine isocoumarin amide, synthesis and uses thereof |
| 06/01/2011 | CN101361732B Medicinal preparation containing garcinia acid and use thereof |
| 06/01/2011 | CN101353361B Preparation of adriablastina prodrug and use thereof |
| 06/01/2011 | CN101342244B Traditional Chinese medicine bone setting powder for treating rheumatism bone disease based on hot-salt method |
| 06/01/2011 | CN101332228B Traditional Chinese medicine composition for treating disease with common pathogenic basis of 'insulin resistance', such as type II diabetic |
| 06/01/2011 | CN101314603B Valine protected imidazo-[1,2-a] purine three-loop base opened-loop nucleoside compounds, preparation method and application thereof |
| 06/01/2011 | CN101302235B Purification of picoplatin |
| 06/01/2011 | CN101249215B Medicine for curing burn dressing and method of preparing the same |
| 06/01/2011 | CN101248053B N-oxides as prodrugs of piperazine and piperidine derivatives |
| 06/01/2011 | CN101225049B Beta-elemene amino acid derivatives as well as synthetic method and use thereof |
| 06/01/2011 | CN101219140B Benzydamine Hcl soluble tablet and method for preparing the same |
| 06/01/2011 | CN101204429B Extractive of total peony ladves flavone-glycoides, preparation method and uses thereof |
| 06/01/2011 | CN101194936B Application of giant knotweed rhizome toluylene total glycosides in preparing medicament for treating rheumatic disease |
| 06/01/2011 | CN101189221B Ampa receptor potentiators |
| 06/01/2011 | CN101175729B 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof |
| 06/01/2011 | CN101171252B Tetracyclic azapyrazinoindolines as 5-HT2 ligands |
| 06/01/2011 | CN101166738B Novel crystalline forms of tiotropium bromide |
| 06/01/2011 | CN101129409B Antimycotic externally used drug |
| 06/01/2011 | CN101129341B Intra-oral disintegration compositions and process for producing same |
| 06/01/2011 | CN101125133B Unsaturated fatty acid microcapsule preparing technology and application |
| 06/01/2011 | CN101103995B Application of fly maggot chitosan in preparing product regulating blood sugar |
| 06/01/2011 | CN101099860B Use of erythropoietin |
| 06/01/2011 | CN101084914B Application of ophiopognin saponin D in preparing medicine for regulating vascular endothelial cells apoptosis gene |
| 06/01/2011 | CN101076520B Imidazoline derivatives having cb1-antagonistic activity |
| 06/01/2011 | CN101070300B Linonene anologs and its preparing method and use |
| 06/01/2011 | CN101062021B Diarrhea treating medical composition |
| 05/31/2011 | USRE42412 Materials and methods for the treatment of gastroesophageal reflux disease |
| 05/31/2011 | US7951979 2,4,6-trisubstituted phenols having anesthetic properties |
| 05/31/2011 | US7951973 N-(1-methyl-2Phenylethyl)benzamide derivatives |
| 05/31/2011 | US7951972 Human adam-10 inhibitors |
| 05/31/2011 | US7951958 Imidazole compounds for the treatment of neurodegenerative disorders |
| 05/31/2011 | US7951957 Substituted benzimidazoles and their use for inducing apoptosis |
| 05/31/2011 | US7951956 Benzoimidazole compound capable of inhibiting prostaglandin D synthetase |
| 05/31/2011 | US7951955 Antiviral agents |
| 05/31/2011 | US7951954 Bezothiazol derivatives as Beta2 adrenoreceptor agonists |
| 05/31/2011 | US7951951 Bicyclic enamino(thio)carbonyl compounds |
| 05/31/2011 | US7951949 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 05/31/2011 | US7951936 Formed by freezing photoreactive polysaccharide (hyaluronic acids) solution, then irradiating to crosslink; requires no removal of solvent |
| 05/31/2011 | US7951925 Using zinc finger protein nuclease as therapeutic tool in treatment and prevention of viral infection |
| 05/31/2011 | US7951888 Block copolymer, composition comprising it and cosmetic treatment process |
| 05/31/2011 | US7951847 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 05/31/2011 | US7951846 pH-sensitive polymeric micelles for drug delivery |
| 05/31/2011 | US7951845 Composition and method of treating hearing loss |
| 05/31/2011 | US7951844 Tranquilizer and functional food |
| 05/31/2011 | US7951843 Amide linked modulators of γ-secretase |
| 05/31/2011 | US7951842 cosmetic; promotes excellent softness and mildness to skin and hair while exhibiting high-foam performance |
| 05/31/2011 | US7951841 9-Cis- or 11-cis-retinyl succinate, citrate, ketoglutarate, fumarate, malate or oxaloacetate; administering to vertebrate having an endogenous retinoid deficiency; vision defects; 9-cis-retinyl acetate or 9-cis-retinyl succinate; photoreceptor stabilizers; macular degeneration |
| 05/31/2011 | US7951840 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/31/2011 | US7951839 6R-(3,6-dideoxy-L-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof |
| 05/31/2011 | US7951838 Substituted spirocyclic chromanamine compounds as Beta-Secretase modulators and methods of use |
| 05/31/2011 | US7951837 Crystalline forms of duloxetine free base |
| 05/31/2011 | US7951836 Substituted phenyl methanone derivatives |
| 05/31/2011 | US7951835 Crystals of non-natural-type stereoisomer salt of monatin and use thereof |
| 05/31/2011 | US7951834 Angiotensin I-converting enzyme (ACE) inhibitors |
| 05/31/2011 | US7951833 Crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic acid 471 |
| 05/31/2011 | US7951832 Pyrazole derivatives as kinase inhibitors |
| 05/31/2011 | US7951831 Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors |
| 05/31/2011 | US7951830 Compounds effecting glucokinase |
| 05/31/2011 | US7951828 Isoxazoline-substituted benzamide compound and pesticide |
| 05/31/2011 | US7951827 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles |
| 05/31/2011 | US7951826 Obesity; cognition activators; narcolepsy |
| 05/31/2011 | US7951825 Hetero compound |
| 05/31/2011 | US7951824 4-aryl-pyridine-2-carboxyamide derivatives |
| 05/31/2011 | US7951823 Compounds and compositions as channel activating protease inhibitors |
| 05/31/2011 | US7951822 1,3-dihydroisobenzofuran derivatives |
| 05/31/2011 | US7951821 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951819 Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds |
| 05/31/2011 | US7951818 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 05/31/2011 | US7951817 Pyridomorphinans, pyridazinomorphinans and use thereof |
| 05/31/2011 | US7951816 Compound containing basic group and use thereof |
| 05/31/2011 | US7951815 Substituted 1,4,8-triazaspiro [4,5]decan-2-one compounds |
| 05/31/2011 | US7951814 Quinazolinedione derivatives as TRPA1 modulators |
| 05/31/2011 | US7951813 Quinazolinone derivatives as ALDH-2 inhibitors |
| 05/31/2011 | US7951812 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007) |
| 05/31/2011 | US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group |
| 05/31/2011 | US7951810 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes |
| 05/31/2011 | US7951809 Inhibitors of p38 |
| 05/31/2011 | US7951808 Imidazole compounds |
| 05/31/2011 | US7951807 Substituted oxindol derivatives and medicaments containing the same |
| 05/31/2011 | US7951806 Plasminogen activator inhibitor-1 inhibitor |